Requip is the first drug approved for restless legs syndrome
June 2005
Requip is the first drug approved for restless legs syndrome.
About 10% of Americans get these overpowering urges to move their legs...especially when at rest.
Ropinirole (Requip) is a dopamine agonist...like pramipexole (Mirapex) and pergolide (Permax). They're thought to help by boosting dopamine, a neurotransmitter that controls movement.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote